Trinity Biotech (TRIB) Total Debt (QoQ) (2009 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 11.45% |
| Sep 30, 2024 | -1.21% |
| Jun 30, 2024 | 14.62% |
| Mar 31, 2024 | 44.39% |
| Dec 31, 2023 | 1.72% |
| Sep 30, 2023 | 0.39% |
| Jun 30, 2023 | -19.12% |
| Mar 31, 2023 | 11.06% |
| Dec 31, 2022 | 0.36% |
| Sep 30, 2022 | -4.02% |
| Jun 30, 2022 | -39.68% |
| Mar 31, 2022 | 245,854.84% |
| Jun 30, 2012 | -57.14% |
| Mar 31, 2012 | -35.19% |
| Dec 31, 2011 | -28.95% |
| Sep 30, 2011 | -13.64% |
| Jun 30, 2011 | 1.15% |
| Mar 31, 2011 | 7.41% |
| Dec 31, 2010 | -38.87% |
| Sep 30, 2010 | -9.86% |
| Jun 30, 2010 | -98.21% |
| Mar 31, 2010 | -14.67% |
| Dec 31, 2009 | 8.75% |
| Sep 30, 2009 | -14.20% |
| Jun 30, 2009 | 175.77% |